Entera Bio Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.50
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2022-06-30
|
-0.16
|
-0.11
|
0.05
|
31.25%
|
|
2022-03-31
|
-0.18
|
-0.13
|
0.05
|
27.78%
|
|
2021-12-31
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2021-09-30
|
-0.11
|
-0.09
|
0.02
|
18.18%
|
|
2021-06-30
|
-0.12
|
-0.21
|
-0.09
|
-75.00%
|
|
2021-03-31
|
-0.12
|
-0.43
|
-0.31
|
-258.33%
|
|
2020-12-31
|
-0.14
|
-0.13
|
0.01
|
7.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.35
|
|
2021-12-31
|
-0.94
|
|
2020-12-31
|
-0.23
|
|
2019-12-31
|
-0.89
|
|
2018-12-31
|
44.27
|
|
2017-12-31
|
-0.63
|
|
2016-12-31
|
-0.22
|